Eric Lefkofsky Builds A Holistic Approach to Look at All Angles of Cancer Management

Eric Lefkofsky is a busy man. He is involved in numerous businesses, the most prominent one being that he is the co-found and Chairman of Groupon. He is also involved in starting six other companies, one in which he was a founding investor.

One of his newest companies is Tempest, a health database company that is seen as super ambitious. While this may come as a shock to many given that none of his past businesses dealt with health when he explains that in each of these companies he helped to organize messy data, we begin to understand more of his why.

The company takes structured clinical data and combines it with molecular data. Looking at many patients, the drugs they are using, and how the patients are reacting to them helps doctors to understand how to help others with cancer. Lefkofsky notes that a big part of why this is working is because we live in an era where saving this data can be done at a reasonable price. He did point out as well that the major difference between Tempus and other companies is that his company is not looking to prevent but to manage the disease. Up until this point, people in the medical field were able to get good data but could only solve one part of the problem. Combining these three different combinations takes a holistic approach looking at all the data.

One question he has been asked about Tempus is his outlook on companies like Apple and Amazon getting into the health data industry as well. Eric Lefkofsky takes a positive outlook on it, feeling that this data should help keep people alive and encourage them to have a better life while they are at it.

Today twenty-five percent of cancer patients go through his sequencing, in five years he thinks that it will be one hundred percent.

In addition to his work with Tempus, Lefkofsky started a non-profit organization with his wife in 2006. The Lefkofsky Family Foundation supports the Chicago community that he lives in. He also has a book out and is an adjunct professor at the University of Chicago.

For details: